O'Toole David D
- SEC CIK
- 0001491140
In the past year, 5 open-market purchase filings worth $46.0K and no sales.
Current role at each company
- RCEL AVITA Medical, Inc.CFOas of Aug 24, 2026
- OPNT Opiant Pharmaceuticals, Inc.Chief Financial Officeras of Mar 3, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $46.0K
- 5 filings
- Sold
- –
- 0 filings
- Net
- +$46.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists O'Toole David D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RCEL AVITA Medical, Inc.
CFO20 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:00 PM ET | Jun 12 | 73 days | O'Toole David DCFO | PPurchase | +2.00K | $3.97 | +$7.94K | +1.3%152.9K after | Amended |
| May 20, 2026 (view filing) | May 20 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $4.26 | +$8.52K | +1.4%145.9K after | |
| May 19, 2026 (view filing) | May 19 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $4.24 | +$8.48K | +1.4%143.9K after | |
| Mar 11, 2026 (view filing) | Mar 11 | Same day | O'Toole David DCFO | PPurchase | +1.80K | $4.78 | +$8.60K | +1.3%141.9K after | |
| Feb 23, 2026 (view filing) | Feb 19 | 4 days | O'Toole David DCFO | PPurchase | +3.00K | $4.15 | +$12.4K | +2.2%140.1K after | |
| Aug 26, 2025 (view filing) | Aug 26 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $4.52 | +$9.04K | +6.7%31.7K after | |
| Aug 12, 2025 (view filing) | Aug 12 | Same day | O'Toole David DCFO | PPurchase | +2.00K | $4.81 | +$9.62K | +7.2%29.7K after | |
| Feb 20, 2025 (view filing) | Feb 20 | Same day | O'Toole David DCFO | PPurchase | +1.00K | $9.90 | +$9.90K | +4.0%25.7K after | |
| Feb 19, 2025 (view filing) | Feb 19 | Same day | O'Toole David DCFO | PPurchase | +1.00K | $10.25 | +$10.3K | +4.2%24.7K after | |
| Dec 5, 2024 (view filing) | Dec 5 | Same day | O'Toole David DCFO | PPurchase | +975 | $12.46 | +$12.2K | +4.3%23.7K after | 2 lots |
OPNT Opiant Pharmaceuticals, Inc.
Chief Financial Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 (view filing) | Jan 27 | 4 days | O'Toole David DChief Financial Officer | SSale | −541 | $20.26 | −$11.0K | −1.6%34.2K after | |
| Jan 9, 2023 (view filing) | Jan 9 | Same day | O'Toole David DChief Financial Officer | SSale | −415 | $20.20 | −$8.38K | −1.2%34.8K after | |
| Jan 5, 2023 (view filing) | Jan 5 | Same day | O'Toole David DChief Financial Officer | SSale | −1.60K | $20.20 | −$32.3K | −4.3%35.2K after | |
| Jul 15, 2022 (view filing) | Jul 14 | 1 day | O'Toole David DChief Financial Officer | SSale | −779 | $11.10 | −$8.65K | −2.1%36.8K after | |
| Jan 12, 2022 (view filing) | Jan 10 | 2 days | O'Toole David DChief Financial Officer | SSale | −432 | $30.60 | −$13.2K | −1.2%35.6K after | |
| Sep 15, 2021 (view filing) | Sep 14 | 1 day | O'Toole David DChief Financial Officer | PPurchase | +200 | $19.12 | +$3.82K | +0.8%24.0K after | 2 lots |
| Aug 16, 2021 (view filing) | Aug 16 | Same day | O'Toole David DChief Financial Officer | PPurchase | +600 | $15.38 | +$9.23K | +2.6%23.8K after |